Pharmacological inhibition of fatty acid amide hydrolase (FAAH) activity
leads to increased levels of fatty acid amides. The alkylcarbamic acid
aryl ester of Formula (I), KDS-4103, is a FAAH inhibitor. Described
herein is a process for the preparation of the compound of Formula (I),
characterization of polymorphs of the FAAH inhibitor, and their uses
therof.